Prevalence of active Charcot disease in the East Midlands of England
dc.contributor.author | Bunting, D | |
dc.date.accessioned | 2019-06-05T12:59:05Z | |
dc.date.available | 2019-06-05T12:59:05Z | |
dc.date.issued | 2018-10 | |
dc.identifier.citation | Diabet Med. 2018 Oct;35(10):1371-1374. doi: 10.1111/dme.13679. Epub 2018 Jun 2. | en |
dc.identifier.uri | http://hdl.handle.net/20.500.12904/1641 | |
dc.description | Author(s) Pre Print. 12 Month Embargo on Post-Print. No PDF | en |
dc.description.abstract | AIMS: To undertake a prospective point prevalence study of the prevalence of active Charcot neuro-inflammatory osteoarthropathy (Charcot disease) in a circumscribed part of England and to audit the time elapsing between disease onset and first diagnosis. METHODS: The prevalence of active Charcot disease of the foot during a single month was assessed by specialist foot care teams at seven secondary care services in the East Midlands region of England. RESULTS: A total of 90 cases were identified, representing 4.3 per 10 000 of the 205 033 total diabetes population of the region. The time elapsed from first presentation to any healthcare professional until diagnosis was also assessed. While the diagnosis was suspected or confirmed in one-third of patients within 2 weeks, it was not made for 2 months or more in 23 patients (24%). CONCLUSIONS: Non-specialist professionals should have greater awareness of the existence of this uncommon complication of diabetes in the hope that earlier diagnosis will lead to lesser degrees of deformity. | en |
dc.language.iso | en | en |
dc.subject | Charcot Disease | en |
dc.subject | Charcot Neur-Inflammatory Osteoarthropathy | en |
dc.title | Prevalence of active Charcot disease in the East Midlands of England | en |
dc.type | Article | en |